MICALLEF JACOB VINCENT (Chief Scientific Officer) purchased 9.3% of their position (20K shares) of VOLITIONRX LTD on the open market
Open‑market purchase worth $24.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/28/2023ACC: 0001477932-23-006497
Officer· Chief Scientific Officer
+20K
Net shares
Net buyer
$24.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$1.24
Trade value
$24.80K
% of position
9.3%
—
215.14K→235.14K
Total
Net shares
+20K
Net value
$24.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +20K | $1.24 | $24.80K | 9.3% | 215.14K | 235.14K |
| Total | +20K | $24.80K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned38.11K
Common Stock
IndirectShares owned35K
Total
73.11K indirect73.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 38.11K | Indirect |
| Common Stock | 35K | Indirect |
| Total | 73.11K | 73.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported